Form 8-K - Current report:
SEC Accession No. 0001564590-21-025567
Filing Date
2021-05-07
Accepted
2021-05-07 16:15:34
Documents
2
Period of Report
2021-05-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K inzy-8k_20210506.htm 8-K 34066
2 EX-10.1 inzy-ex101_22.htm EX-10.1 99489
  Complete submission text file 0001564590-21-025567.txt   134874
Mailing Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210
Business Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210 857-330-4340
Inozyme Pharma, Inc. (Filer) CIK: 0001693011 (see all company filings)

EIN.: 475129768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39397 | Film No.: 21902839
SIC: 2834 Pharmaceutical Preparations